Results 151 to 160 of about 162,947 (233)

Bacterial bloodstream infections in pediatric oncology patients in a tertiary medical center: pathogen distribution, antimicrobial nonsusceptibility, and outcomes. [PDF]

Eur J Pediatr
Jurkowicz M, Leibovitz E, Rosental H, Keller N, Sherman G, Dresner E, Katzenellenbogen G, Gelman E, Paret M, Myaskovetzky-Yitshack R, Golan H, Barg A, Toren A, Stein M.   +13 more
europepmc   +1 more source

Clinical Considerations of Amikacin Pharmacotherapy in Adults-A Narrative Review with Focus on Safety and TDM. [PDF]

Antibiotics (Basel)
Orzechowski D, Mroczkowska A, Bryła A, Rapacz A.   +3 more
europepmc   +1 more source

Radiographic severity and treatment optimisation in <i>Mycobacterium avium</i> complex pulmonary disease. [PDF]

ERJ Open Res
Cho Y, Bae J, Kim JY, Yim JJ, Yoon SH, Kwak N.   +5 more
europepmc   +1 more source

Feline Cutaneous Mycobacteriosis Caused by <i>Mycobacterium farcinogenes</i>: The First Case Report from Asia. [PDF]

Animals (Basel)
Chuenngam T, Promsatit W, Khamduang C, Vilaiwan K, Kanjanasri K.   +4 more
europepmc   +1 more source

Amikacin bladder instillation as prophylaxis for recurrent urinary tract infections in a child with neurogenic bladder: A case report. [PDF]

IDCases
Alsunaidi A, Alsalem AA, Aldajani YA, Alsubaie S.   +3 more
europepmc   +1 more source

Prevalence and Antimicrobial Resistance of <i>Pseudomonas aeruginosa</i> Recovered from Respiratory and Urinary Specimens in a Lebanese Hospital (2020-2025). [PDF]

Infect Dis Rep
Barakat R, Ezzeddine Z, El Haidari R, Hassan S, Ghssein G.   +4 more
europepmc   +1 more source

Successful treatment of inducible macrolide-resistant <i>Mycobacterium abscessus</i> subspecies <i>abscessus</i> surgical site infection after cosmetic surgery. [PDF]

IDCases
Nagase Y, Nomoto H, Kamada K, Yokochi R, Iizawa A, Ujiie M, Ohmagari N.   +6 more
europepmc   +1 more source

Reciprocal adaptation is critical in enhancing S. aureus and P. aeruginosa biofilm biomass. [PDF]

Arch Microbiol
Sun X, Cooksley CM, Awad M, Barry EF, Psaltis AJ, Wormald PJ, Vreugde S.   +6 more
europepmc   +1 more source

Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept study. [PDF]

Antimicrob Agents Chemother
Walker MM, Roberts JA, Li Y, Naicker S, Wallis SC, Ordonez JL, Won H, Forde BM, Sime FB.   +8 more
europepmc   +1 more source

Essential fatty acids disrupt the mycolic acid-rich cell envelope of clinical <i>Nocardia</i> isolates: a membrane-targeting approach to combat persistent infections. [PDF]

Front Cell Infect Microbiol
Wei M, Xie S, Wang P, Li T, Liu J, Yang J, Xu X, Luo D, Gu L, Wang S.   +9 more
europepmc   +1 more source